Joseph A. Geraci II - 23 Nov 2022 Form 4/A - Amendment Insider Report for Mill City Ventures III, Ltd (MCVT)

Role
Chief Financial Officer, Director
Signature
/s/ Joseph A. Geraci, II
Issuer symbol
MCVT
Transactions as of
23 Nov 2022
Transactions value $
$0
Form type
4/A - Amendment
Filing time
01 Dec 2022, 20:57:53
Date Of Original Report
25 Nov 2022
Previous filing
23 Sep 2022
Next filing
09 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MCVT Common Stock 7.68K 23 Nov 2022 By spouse
holding MCVT Common Stock 129K 23 Nov 2022 By Lantern Advisers LLC F1
holding MCVT Common Stock 326K 23 Nov 2022 Direct F2
holding MCVT Common Stock 445 23 Nov 2022 By self as UTMA custodian for minor child F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCVT Non-qualified stock option Award $0 +250K $0.00 250K 23 Nov 2022 Common stock 250K $2.12 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A Minnesota limited liability company of which the reporting person is a member and manager. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
F2 Of the reported amount, 10,000 common shares are subject to forfeiture pursuant to a restricted stock agreement with the issuer. Subject to the terms of the restricted stock grant agreement, those 10,000 shares are scheduled to vest on January 24, 2023.
F3 These common shares were transferred as a bona fide gift but remain "beneficially owned" under 17 CFR 240.13d-3. The reporting person disclaims beneficial ownership of these shares.
F4 Options were issued to the reporting person pursuant to an award approved, without restrictions, by the Compensation Committee of the Board of Directors of the issuer on November 23, 2022. The exercise price is the closing market price of the common stock on the date of the award.
F5 The options are not exercisable by their terms unless and until the related equity compensation plan shall have been approved by the issuer's shareholders.

Remarks:

This amendment is being filed to correct a reporting error in the original filing indicating that the award made on 11/23/2022 was a stock award. Accordingly, the relevant row in Table I has been removed and the corrected information now appears in Table II.